FJ Research

FJ Research

Natera: Q3 2026 Research Update. I´m back in!

Why the sell-off is an entry, not an exit.

FJ Research's avatar
FJ Research
Nov 18, 2026

I’ve followed Natera for years. I sold the position earlier (+90% profit) to concentrate into SpaceX, Lilly & Pershing Square. After the Q3 volume trajectory and guidance raise, the CEO transition, and the subsequent drop, I’m getting back in. The core volume and evidence story is intact and the leadership handoff is internal. The post-earnings drop giv…

Subscribe for free to continue reading

Enter your email and get every post from FJ Research.
Already have an account? Sign in
© 2026 FJ Research · Privacy ∙ Terms ∙ Collection notice
Start your SubstackGet the app
Substack is the home for writing, podcasting, and media founders.